|
EP2928915A4
(en)
*
|
2012-12-07 |
2016-07-27 |
Permeon Biolog Inc |
FGF-10 COMPLEX
|
|
EP3610884B1
(en)
*
|
2013-11-06 |
2021-08-18 |
Merck Sharp & Dohme Corp. |
Peptide containing conjugates for dual molecular delivery of oligonucleotides
|
|
BR112016013516A8
(pt)
*
|
2013-12-12 |
2020-05-19 |
Life Technologies Corp |
complexo de transfecção e seu uso para aumentar transporte de molécula de carga em células e para o tratamento de câncer e terapia gênica, bem como método in vitro para fornecer um poliânion a uma célula
|
|
WO2015109012A1
(en)
*
|
2014-01-14 |
2015-07-23 |
Integrated Biotherapeutics, Inc. |
Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
|
|
WO2015121457A1
(en)
|
2014-02-13 |
2015-08-20 |
Westphal Sören |
Fgf-8 for use in treating diseases or disorders of energy homeostasis
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
FI3218005T3
(fi)
|
2014-11-12 |
2023-03-31 |
Seagen Inc |
Glykaanin kanssa vuorovaikutteisia yhdisteitä ja käyttömenetelmiä
|
|
WO2016172187A1
(en)
*
|
2015-04-20 |
2016-10-27 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods and compositions related to kras inhibitors
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US9957325B2
(en)
|
2015-10-13 |
2018-05-01 |
Formurex, Inc. |
Synthetic antibody mimic peptides
|
|
CA3002097A1
(en)
|
2015-11-12 |
2017-05-18 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
WO2017120213A1
(en)
*
|
2016-01-05 |
2017-07-13 |
Colorado State University Research Foundation |
Compositions comprising resurfaced cell-penetrating nanobodies and methods of use thereof
|
|
US11318139B2
(en)
|
2016-01-26 |
2022-05-03 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents
|
|
CN105837665B
(zh)
*
|
2016-05-16 |
2019-04-30 |
江苏大学 |
特异性抑制hb-egf促肿瘤细胞迁移浸润的多肽
|
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
|
US11524988B2
(en)
|
2016-09-19 |
2022-12-13 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Artificial antigen presenting cells for genetic engineering of immune cells
|
|
WO2018094143A1
(en)
|
2016-11-17 |
2018-05-24 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
CN110139870B
(zh)
*
|
2016-12-16 |
2023-12-01 |
爱维斯健有限公司 |
细胞膜穿透肽及包含其的细胞内输送载体
|
|
WO2018111051A1
(ko)
*
|
2016-12-16 |
2018-06-21 |
(주)에빅스젠 |
세포막 투과 펩티드 및 이를 포함하는 세포내 전달체
|
|
WO2018156735A1
(en)
*
|
2017-02-22 |
2018-08-30 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Bispecific antibody for cancer immunotherapy
|
|
WO2018160909A1
(en)
|
2017-03-03 |
2018-09-07 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
KR101933217B1
(ko)
*
|
2017-12-28 |
2018-12-27 |
(주) 에빅스젠 |
피부 염증 억제용 펩티드 및 이를 포함하는 피부 염증 예방 또는 치료용 조성물
|
|
US12150973B2
(en)
|
2018-05-03 |
2024-11-26 |
University Of Utah Research Foundation |
OCA-B peptide conjugates and methods of treatment
|
|
CN112912103B
(zh)
*
|
2018-05-21 |
2025-08-29 |
广州邦定生物技术有限公司 |
多价蛋白质复合物
|
|
EP3808840A4
(en)
*
|
2018-06-14 |
2022-03-23 |
Avixgen Inc. |
Pharmaceutical composition comprising fusion protein of cell-penetrating peptide and rpe65 for treatment of leber's congenital amaurosis
|
|
JP7113918B2
(ja)
*
|
2018-06-14 |
2022-08-05 |
アヴィックスジェン・インコーポレイテッド |
細胞透過ペプチドと結合した融合タンパク質、および融合タンパク質または細胞透過ペプチドと上皮細胞成長因子を有効成分として含む組成物
|
|
GB201815045D0
(en)
|
2018-09-14 |
2018-10-31 |
Univ Ulster |
Bispecific antibody targeting IL-1R1 and NLPR3
|
|
KR102611974B1
(ko)
*
|
2020-02-06 |
2023-12-11 |
아주대학교산학협력단 |
항원 유래 t 세포 항원 에피토프 또는 이를 포함하는 펩타이드를 세포 표면에 제시하기 위한 융합항체, 및 이를 포함하는 조성물
|
|
US20240401032A1
(en)
*
|
2020-05-04 |
2024-12-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions, systems, and methods for the generation, identification, and characterization of effector domains for activating and silencing gene expression
|
|
CN116194132A
(zh)
*
|
2020-07-13 |
2023-05-30 |
新加坡国立大学 |
肽佐剂对于其在病毒和肿瘤疫苗开发以及癌症免疫疗法和自身免疫性疾病诊断和治疗中的治疗应用
|
|
CA3223191A1
(en)
*
|
2021-09-03 |
2023-03-09 |
University Of Utah Research Foundation |
Compositions and methods for diagnosing, detecting and treating eosinophil-related diseases
|
|
CN117736338A
(zh)
*
|
2023-12-08 |
2024-03-22 |
温州医科大学 |
一种角质细胞生长因子-透皮肽融合蛋白及其制备与应用
|
|
EP4711380A1
(en)
*
|
2024-09-16 |
2026-03-18 |
Fundació Institut Hospital del Mar d'Investigacions Mèdiques |
Ligand-dependent corepressor, (lcor), mutants and fragments thereof, and uses for cancer therapy
|